Salfaprodil

索法地尔

Report date: 2024/05/10 11:46:24
NME

Base Information

Drug NameSalfaprodil
Drug Alias NameNelonemdaznelonemdaz potassiumGantinel InjectionGantinelNeu2000KWL +[7] 
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor subunit epsilon 2 inhibitorsantioxidant
TargetsGlutamate [NMDA] receptor subunit epsilon 2
Therapy Area/IndicationsIschemic StrokeStrokeCerebral Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesGnt Pharma
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesGnt PharmaHengdian Group Jiayuan Chemical Co LtdZhejiang Apeloa Medical Technology Co Ltd +[4] 
Inactive CompaniesZhejiang Apeloa Jiayuan Pharmaceutical Co Ltd
Active IndicationsIschemic StrokeStroke
Inactive IndicationsCerebral Infarction

Other Information

ATC CodeN/A
Related LinksN/A